Literature DB >> 18938083

Persistent symptoms following non operative management in low grade MCL injury of the knee - The role of the deep MCL.

Luke Jones1, Quamar Bismil, Faisal Alyas, David Connell, Jonathan Bell.   

Abstract

Incomplete injuries (grade I or II) to the medial collateral ligament (MCL) of the knee are common and usually self limiting. Some patients complain of chronic medial knee pain following injury. We highlight the importance of anatomical investigation of these patients and evaluate a successful treatment technique. A consecutive case series of 34 patients with chronic pain following grade I/II MCL injury were reviewed. Injury prevented sporting activity, and examination revealed thickening and tenderness of the MCL. The knee was assessed by MRI. All patients had radiological evidence of injury to the superficial and deep MCL, with thickening, scarring and tearing. Patients were treated with ultrasound guided injection of local anaesthetic and steroid into the deep MCL and clinically reassessed. They were allowed to return to sport immediately. They were assessed for recurrence of symptoms with a postal questionnaire. Four were excluded from follow up. Four were lost. All patients reported an immediate and sustained resolution their medial knee pain. At mean follow up of 20.4 months (range 11-38 months) all were back to their pre-injury level of work. Twenty five (96%) had immediate and sustained return to sporting activity. Twenty one (81%) reported no change in level of sporting function. In patients with persistent medial joint pain following grade I/II MCL sprain, pain from the deep MCL must be considered. MRI will confirm the diagnosis, exclude coexistent pathology and localise the lesion within the deep MCL. A single corticosteroid injection provides an excellent clinical outcome 20 months post injection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938083     DOI: 10.1016/j.knee.2008.09.002

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  8 in total

1.  Consideration of growth factors and bio-scaffolds for treatment of combined grade II MCL and ACL injury.

Authors:  Natasha Anoka; John Nyland; Mark McGinnis; Dave Lee; Mahmut Nedim Doral; David N M Caborn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-10       Impact factor: 4.342

Review 2.  Structure and function, injury, pathology, and treatment of the medial collateral ligament of the knee.

Authors:  Aaron Schein; George Matcuk; Dakshesh Patel; Christopher J Gottsegen; Timothy Hartshorn; Deborah Forrester; Eric White
Journal:  Emerg Radiol       Date:  2012-08-14

3.  Medial collateral ligament (MCL) reconstruction results in improved medial stability: results from the Danish knee ligament reconstruction registry (DKRR).

Authors:  Martin Lind; Kevin Jacobsen; Torsten Nielsen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-05-23       Impact factor: 4.342

Review 4.  Clinical assessment of antero-medial rotational knee laxity: a systematic review.

Authors:  Dinesh Sirisena; Enrica Papi; Eleanor Tillett
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-27       Impact factor: 4.342

5.  In vivo length patterns of the medial collateral ligament during the stance phase of gait.

Authors:  Fang Liu; Hemanth R Gadikota; Michal Kozánek; Ali Hosseini; Bing Yue; Thomas J Gill; Harry E Rubash; Guoan Li
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-11       Impact factor: 4.342

6.  Return-to-Play Times and Player Performance After Medial Collateral Ligament Injury in Elite-Level European Soccer Players.

Authors:  Ophelie Z Lavoie-Gagne; Julia Retzky; Connor C Diaz; Nabil Mehta; Avinaash Korrapati; Enrico M Forlenza; Derrick M Knapik; Brian Forsythe
Journal:  Orthop J Sports Med       Date:  2021-09-28

7.  Clinical Outcomes of Repair of Complete Detachment of Medial Collateral Ligament at the Tibial Insertion in Bilateral Total Knee Arthroplasty.

Authors:  Cheng Jin; Eun-Kyoo Song; Quan-He Jin; Jong-Keun Seon; Si-Mei Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-21       Impact factor: 2.650

8.  Autologous platelet-rich plasma therapy for refractory pain after low-grade medial collateral ligament injury.

Authors:  Guoyou Zou; Minqian Zheng; Wang Chen; Xiao He; Dingwei Cang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.